Concepedia

Amanda Littlewood‐Evans

AL

33

Publications

3.3K

Citations

29

H-Index

1997

Active since

Affiliations

Novartis (Switzerland)(Current)

Novartis Institutes for BioMedical Research

Novartis (United States)

University of Liverpool

Amanda Littlewood‐Evans is an author at Novartis (Switzerland) specializing in medicine, immunology, and inflammation.

ORCID

Top concepts

Publications per year

1997–2023

33

Publications

33

GPR91 senses extracellular succinate released from inflammatory macrophages and exacerbates rheumatoid arthritis

Amanda Littlewood‐Evans, Sophie Sarret, Verena Apfel et al. · The Journal of Experimental Medicine · 2016 · 467 citations · Full text

, , +23

Antagonism of Sphingosine-1-Phosphate Receptors by FTY720 Inhibits Angiogenesis and Tumor Vascularization

Kenneth R. LaMontagne, Amanda Littlewood‐Evans, Christian Schnell et al. · Cancer Research · 2006 · 297 citations

mTOR Inhibitor RAD001 (Everolimus) Has Antiangiogenic/Vascular Properties Distinct from a VEGFR Tyrosine Kinase Inhibitor

Heidi A. Lane, Jeanette M. Wood, Paul M.J. McSheehy et al. · Clinical Cancer Research · 2009 · 250 citations · Full text

Small-molecule factor B inhibitor for the treatment of complement-mediated diseases

Anna Schubart, Karen Anderson, Nello Mainolfi et al. · Proceedings of the National Academy of Sciences · 2019 · 206 citations · Full text

, , +23

TNF leads to mtDNA release and cGAS/STING-dependent interferon responses that support inflammatory arthritis

Joschka Willemsen, Marie‐Therese Neuhoff, Thomas Hoyler et al. · Cell Reports · 2021 · 197 citations · Full text

, , +18

Rows per page

1–5 of 33